Normal Tissue Tolerance in SBRT & Radiotherapy: Lessons from QUANTEC
John Kirkpatrick, MD, from the radiation oncology department at Duke University in Durham, North Carolina reveals lessons learned from QUANTEC about normal tissue tolerance in stereotactic radiotherapy (SRT) and radiosurgery (SRS). He discusses the rationale, methodology and background of QUANTEC, its application to SRT and SRS, and the opportunities for improvement.
About the speaker
John P. Kirkpatrick, MD, PhD
Duke University Medical Center, USA
Related Videos
-
Normal Tissue Tolerance in SBRT & Radiotherapy: Lessons from QUANTEC 2
-
Novalis SBRT for Primary and Metastatic Lung Cancers
-
Frameless SRS
-
The Geometric Accuracy of Frameless SRS Using a 6D Robotic Couch
-
Novalis-based SBRT for Lung Malignancies: Normal Tissue Toxicity and Clinical Outcomes
-
Survival Time After RS and hfSRT of Brain Metastases
-
ExacTrac-based Multi-Leaf Collimator Tracking for RapidArc
-
Large AVMs Treated with Hypofractionated SRS
Interested in watching this clinical talk? Please click on the button “WATCH Video” to enter your contact details and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Video related updates.
WATCH VideoKeep Watching
Thank you for watching! Please enter your contact details below to continue watching and to have access to two additional videos from the member-only Novalis Circle. Your contact information will only be used to contact you about Novalis Circle video related updates.
Watch video No ThanksAlready Novalis Circle Member?
Member LoginRegister now
Thank you for your interest in our Novalis Circle videos. Full-access to the media library is currently available for Novalis Radiosurgery users only. If you are a customer, please register or login to continue.